Tesaro Biopharmaceuticals
135 Clarendon Street #14R
Boston
Massachusetts
02116
United States
Website: http://tesarobio.com/
Email: contact@tesarobio.com
50 articles about Tesaro Biopharmaceuticals
-
Tesaro, Inc. Appoints Robert E. Martell, M.D., Ph.D. as Chief Medical Officer
9/5/2012
-
Tesaro, Inc. to Present at Upcoming Conferences
8/30/2012
-
Tesaro, Inc. Announces Second Quarter 2012 Operating Results
7/26/2012
-
Tesaro, Inc. Announces Exercise of Underwriters' Over-Allotment Option
7/25/2012
-
Tesaro, Inc. to Announce Second Quarter 2012 Financial Results on Thursday, July 26th, 2012
7/19/2012
-
Tesaro, Inc. Announces Pricing of Initial Public Offering
6/28/2012
-
Tesaro, Inc. Sets Terms for $81 Million US IPO
6/20/2012
-
Tesaro, Inc. Snags Huge $101 Million Venture Round to Develop Cancer Drugs
6/21/2011
-
Tesaro, Inc. and Opko Health, Inc. Sign Exclusive License Agreement for Rolapitant
12/14/2010
-
Tesaro, Inc. Secures $60 Million in Start-up Funding
5/26/2010